Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Clearmind Medicine

CMND

----

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Clearmind briefs FDA panel at Washington psychedelic drugs hearing
PUBT·Sep 17 at 11:42 AM
CMND-1.19%
Clearmind enrolls first AUD patients in CMND-100 clinical trial
PUBT·Sep 11 at 12:02 PM
CMND-1.19%
Clearmind Medicine Inc. GAAP EPS of -$0.57
businessinsider·Sep 10 at 08:30 PM
CMND-1.19%
Clearmind net loss narrows to USD 907,291 in Q3 FY26; cash climbs to USD 12.04 million at July 31, 2026
PUBT·Sep 10 at 08:08 PM
CMND-1.19%
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results | CMND Stock News
StockTitan·Sep 8 at 03:42 AM
CMND-1.19%
Clearmind Medicine plunges 32% after EV charging deal, drug trial update
US Stock Market Update·Sep 4 at 10:11 PM
CMND-1.19%
Clearmind Medicine jumps 9% in after-hours on EV charging deal, drug trial progress
US Stock Market Update·Sep 4 at 09:01 PM
CMND-1.19%
Clearmind Medicine plunges 28% during regular trading
US Stock Market Update·Sep 4 at 07:40 PM
CMND-1.19%
Clearmind Medicine plunges 24% during regular trading
US Stock Market Update·Sep 4 at 05:55 PM
CMND-1.19%
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga_article·Sep 4 at 05:06 PM
BMY-0.59%IMRN+1.21%
Clearmind Medicine plunges 16% during regular trading
US Stock Market Update·Sep 4 at 03:46 PM
CMND-1.19%
Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis | CMND Stock News
StockTitan·Sep 4 at 03:32 AM
CMND-1.19%
Clearmind Medicine plunges 11% after acquiring Charging Israel stake
US Stock Market Update·Sep 4 at 01:34 PM
CMND-1.19%